However, potentially due to the Trp53−/− status of MB cells leading to high levels of genomic instability while evading apoptosis, we did not observe bulk decreases in tumor cell viability, indicating that PIF1 inhibition may need to be coupled with another therapeutic, such as etoposide or PARP inhibition to lead to tumor cell death. This evidence concerns the gene PIF1 and neoplasm.